glp 1 nafld Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease: could the combinations of an old friend with new players yield better outcomes? Metabolic dysfunction associated fatty liver

The only licensed version of semaglutide indicated for weight loss is Wegovy

Understanding Inflammation Inflammation is the bodys response to injury, infection, toxins, and stress

Our systematic review found that GLP-1 RAs (such as exenatide, liraglutide, semaglutide, and the dual agonist tirzepatide) may significantly improve multiple facets of IIH: headaches, visual function, and induce substantial weight loss

doi: 10.1111/ijcp.14455 105

The patent helps the innovator to profit from its revenue

No adverse effects were reported in a recent exercise study on 16 physically fit individuals supplemented with 20mg per day of Astaxanthin for four weeks